發(fā)布時(shí)間：2018-03-27 07:04

  本文選題：進(jìn)展期宮頸癌　切入點(diǎn)：同步放化療　出處：《放射學(xué)實(shí)踐》2017年04期

【摘要】：當(dāng)今臨床對(duì)于大部分局部進(jìn)展期宮頸癌患者實(shí)行同步放化療的治療方案。但因?yàn)橹委煹挚沟拇嬖?進(jìn)展期宮頸癌的同步放化療的治療效果差強(qiáng)人意,預(yù)后差,易復(fù)發(fā)等問題成為了臨床工作的難題。而動(dòng)態(tài)增強(qiáng)MRI能夠提供更多關(guān)于腫瘤微血管信息,并通過這些信息估計(jì)腫瘤的生物學(xué)特征,為進(jìn)展期宮頸癌的診斷、治療結(jié)果預(yù)測(cè)、預(yù)后評(píng)價(jià)等提供了幫助,為臨床醫(yī)生制定個(gè)性化放化療方案提供了指導(dǎo)。該文綜述了DCE-MRI對(duì)于局部進(jìn)展期宮頸癌同步放化療的短期治療結(jié)果及遠(yuǎn)期預(yù)后的預(yù)測(cè)的應(yīng)用。
[Abstract]:At present, most patients with locally advanced cervical cancer are treated with concurrent radiotherapy and chemotherapy. However, because of the existence of treatment resistance, the effect of concurrent radiotherapy and chemotherapy for advanced cervical cancer is unsatisfactory and the prognosis is poor. But dynamic enhanced MRI can provide more information about tumor microvessel, estimate the biological characteristics of tumor, and predict the treatment result for the diagnosis of advanced cervical cancer. The evaluation of prognosis provides guidance for clinicians to formulate individualized radiotherapy and chemotherapy. This article reviews the application of DCE-MRI in the short-term treatment and long-term prognosis prediction of locally advanced cervical cancer.
【作者單位】： 中國(guó)醫(yī)科大學(xué)腫瘤醫(yī)院遼寧省腫瘤醫(yī)院醫(yī)學(xué)影像科;
【基金】：國(guó)家公益性行業(yè)專項(xiàng)基金(201402020)
【分類號(hào)】：R445.2;R737.33
，

本文編號(hào)：1670497